Distribution Services · Medical Distributors · NSE: MONOPHARMA · data 2026-10-09

Mono Pharmacare Limited

Health check: Weak (2.1/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹8.9

Market cap

₹15 cr

P/E

44.6

P/B

0.5

ROE

2.3%

ROCE

7.6%

Debt / equity

1.77

Dividend yield

0.00%

1-year return

-59.2%

52-week high

₹22.05

52-week low

₹7.5

Operating margin

2.3%

Growth

Revenue (last 12 months)	₹166 cr
Net profit (last 12 months)	₹0 cr
Sales growth, 3 years (yearly)	83.1%
Profit growth, 3 years (yearly)	1.5%

Similar companies

QMS Medical Allied Services Limited (QMSMEDI) · Vijaypd Ceutical Limited (VIJAYPD) · Balaxi Pharmaceuticals Limited (BALAXI) · Aakaar Medical Technologies Limited (AAKAAR) · Vivo Bio Tech Ltd. (VIVOBIOT)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open MONOPHARMA in NSE Scanner →